We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
(+7.8%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$193M |
| 2 |
Gilead Sciences
GILD
|
+$115M |
| 3 |
Tencent Music
TME
|
+$83.5M |
| 4 |
Kanzhun
BZ
|
+$76.7M |
| 5 |
Wheaton Precious Metals
WPM
|
+$68.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$189M |
| 2 |
Williams Companies
WMB
|
+$155M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$94.1M |
| 4 |
AbbVie
ABBV
|
+$87M |
| 5 |
Amgen
AMGN
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.44% |
| 2 | Healthcare | 17.1% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.38% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Zymeworks
ZYME
$1.88B
| $1.9M | ﹤0.01% |
180,547
+180,149
| +45,264% | +$2M |
|
952
PetMed Express
PETS
$34.7M
| $1.88M | ﹤0.01% |
392,527
+354,138
| +922% | +$2.06M |
|
953
Fluor
FLR
$7.09B
| $1.88M | ﹤0.01% |
44,421
+3,556
| +9% | +$137K |
|
954
Tradeweb Markets
TW
$21.6B
| $1.88M | ﹤0.01% |
18,027
-33,537
| -65% | -$3.37M |
|
955
iHeartMedia
IHRT
$395M
| $1.87M | ﹤0.01% |
893,699
-795,106
| -47% | -$1.87M |
|
|
AVNS
956
DELISTED
Avanos Medical
AVNS
| $1.85M | ﹤0.01% |
93,159
+1,395
| +2% | +$27K |
|
957
J.M. Smucker
SJM
$13.2B
| $1.84M | ﹤0.01% |
14,635
-2,096
| -13% | -$265K |
|
958
Red Robin
RRGB
$138M
| $1.84M | ﹤0.01% |
239,999
-73,146
| -23% | -$672K |
|
959
Lear
LEA
$6.08B
| $1.84M | ﹤0.01% |
12,681
-126
| -1% | -$17.2K |
|
960
Lattice Semiconductor
LSCC
$15.1B
| $1.81M | ﹤0.01% |
23,175
-4,215
| -15% | -$302K |
|
961
AGNC Investment
AGNC
$11.7B
| $1.81M | ﹤0.01% |
183,087
-64,296
| -26% | -$620K |
|
962
KBR
KBR
$4.61B
| $1.81M | ﹤0.01% |
28,460
-2,226
| -7% | -$127K |
|
|
NOVA
963
DELISTED
Sunnova Energy
NOVA
| $1.78M | ﹤0.01% |
291,181
-44,553
| -13% | -$402K |
|
964
Globe Life
GL
$13.3B
| $1.78M | ﹤0.01% |
15,274
+1,056
| +7% | +$129K |
|
965
Envista
NVST
$4.01B
| $1.77M | ﹤0.01% |
82,996
-416
| -0.5% | -$9.43K |
|
966
Ollie's Bargain Outlet
OLLI
$4.35B
| $1.77M | ﹤0.01% |
22,271
-327
| -1% | -$24.7K |
|
967
Albemarle Corp Depositary Shares
ALB.PRA
$2.14B
| $1.77M | ﹤0.01% |
+30,000
| New | +$1.69M |
|
968
Keysight
KEYS
$54.8B
| $1.77M | ﹤0.01% |
11,297
+533
| +5% | +$82K |
|
969
HUB Group
HUBG
$2.03B
| $1.76M | ﹤0.01% |
40,633
+397
| +1% | +$17.4K |
|
970
Dollar Tree
DLTR
$21.1B
| $1.75M | ﹤0.01% |
13,158
+1,195
| +10% | +$165K |
|
971
United Therapeutics
UTHR
$21.4B
| $1.75M | ﹤0.01% |
7,623
-76
| -1% | -$17.1K |
|
972
Interface
TILE
$2B
| $1.74M | ﹤0.01% |
103,158
+9,113
| +10% | +$126K |
|
973
Teladoc Health
TDOC
$1.17B
| $1.72M | ﹤0.01% |
114,105
-523,874
| -82% | -$9.51M |
|
974
Masco
MAS
$13.5B
| $1.72M | ﹤0.01% |
21,769
+5,573
| +34% | +$401K |
|
975
Federal Signal
FSS
$7.04B
| $1.71M | ﹤0.01% |
20,190
-9,372
| -32% | -$734K |
|
Similar funds
Federated Hermes's Q1 2024 Portfolio in Review
As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
- Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
- Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
- Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
- Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
- Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
- Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.
Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.